CD30, a cytokine receptor belonging to the tumor necrosis factor receptor (TNFR) superfamily, plays a significant role in the regulation of the immune system. It is predominantly expressed on activated T and B lymphocytes, as well as on some hematopoietic cells, where it participates in a wide array of cellular processes including proliferation, differentiation, and apoptosis. The activation of CD30 is critical for the modulation of immune responses, contributing to both the development and resolution of immune-mediated conditions. Its function is particularly notable in the context of promoting immune cell survival and growth, highlighting its importance in maintaining the balance between effective immune defense mechanisms and the hindering of autoimmune reactions. The receptor operates through the engagement with its ligand, CD30L (CD153), initiating signaling cascades that influence gene expression patterns related to cell survival, cytokine production, and cellular differentiation. This interaction between CD30 and CD30L is essential for the proper functioning of the immune system, playing a pivotal role in the dynamics of immune surveillance and response to pathogenic challenges.
The mechanism of CD30 activation involves the binding of CD30L, leading to the trimerization of the CD30 receptors on the cell surface and subsequent activation of intracellular signaling pathways. This activation triggers the NF-κB and AP-1 transcription factors, which are key regulators of gene expression involved in immune and inflammatory responses. Through these pathways, CD30 influences a variety of cellular functions, including the enhancement of cell survival by upregulating anti-apoptotic genes and promoting the secretion of inflammatory cytokines that facilitate immune cell communication and coordination. Moreover, CD30 signaling is implicated in the regulation of lymphocyte proliferation and contributes to the development and function of effector and memory immune cells. The precise regulation of CD30 activation is therefore crucial for ensuring an appropriate immune response, disrupting the overactivation that could lead to pathological conditions, and maintaining the delicate equilibrium within the immune system. Understanding the molecular mechanisms underlying CD30 activation and its role in immune regulation offers significant insights into the complex interplay of signaling pathways that govern immune homeostasis and the body's defense mechanisms.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Betulinic Acid | 472-15-1 | sc-200132 sc-200132A | 25 mg 100 mg | $115.00 $337.00 | 3 | |
Betulinic Acid is a triterpenoid compound that serves as an indirect activator of CD30 by modulating the NF-κB signaling pathway. Betulinic Acid influences the activation of NF-κB, which, in turn, can indirectly modulate CD30 expression and activity. This indirect activation occurs through the intricate regulatory network connecting NF-κB signaling and CD30, providing a potential avenue for influencing CD30 function in cellular processes. | ||||||
Thymoquinone | 490-91-5 | sc-215986 sc-215986A | 1 g 5 g | $46.00 $130.00 | 21 | |
Thymoquinone is a bioactive compound that acts as an indirect activator of CD30 by affecting the JAK/STAT signaling pathway. Through its modulation of JAK/STAT signaling, Thymoquinone influences the expression and activity of CD30. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Curcumin, a polyphenolic compound, acts as an indirect activator of CD30 by influencing the MAPK/ERK signaling pathway. By modulating MAPK/ERK signaling, Curcumin can indirectly regulate CD30 expression and activity. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $79.00 $300.00 | 32 | |
Parthenolide, a sesquiterpene lactone, serves as an indirect activator of CD30 by targeting the NF-κB signaling pathway. Through its modulation of NF-κB signaling, Parthenolide can influence the expression and activity of CD30. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
Withaferin A, a steroidal lactone, acts as an indirect activator of CD30 by affecting the PI3K/Akt signaling pathway. Through its modulation of PI3K/Akt signaling, Withaferin A can indirectly regulate CD30 expression and activity. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Resveratrol, a natural polyphenol, serves as an indirect activator of CD30 by modulating the JAK/STAT signaling pathway. Through its influence on JAK/STAT signaling, Resveratrol can indirectly regulate CD30 expression and activity. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Celastrol, a triterpenoid compound, acts as an indirect activator of CD30 by targeting the NF-κB signaling pathway. Through its modulation of NF-κB signaling, Celastrol can influence the expression and activity of CD30. | ||||||
Gossypol | 303-45-7 | sc-200501 sc-200501A | 25 mg 100 mg | $114.00 $225.00 | 12 | |
Gossypol, a polyphenolic compound, serves as an indirect activator of CD30 by affecting the PI3K/Akt signaling pathway. Through its modulation of PI3K/Akt signaling, Gossypol can indirectly regulate CD30 expression and activity. | ||||||
Oridonin, R. rubescens | 28957-04-2 | sc-202751 | 5 mg | $77.00 | ||
Oridonin, a diterpenoid compound, acts as an indirect activator of CD30 by modulating the MAPK/ERK signaling pathway. Through its influence on MAPK/ERK signaling, Oridonin can indirectly regulate CD30 expression and activity. | ||||||
Daphnetin | 486-35-1 | sc-203022 | 10 mg | $82.00 | ||
Daphnetin, a coumarin derivative, serves as an indirect activator of CD30 by targeting the JAK/STAT signaling pathway. Through its modulation of JAK/STAT signaling, Daphnetin can indirectly regulate CD30 expression and activity. | ||||||